MWP
BSX icon

Meridian Wealth Partners’s Boston Scientific BSX Stock Holding History

Meridian Wealth Partners’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-178
Closed -$7K – 261
2021
Q1 		$7K Buy
+178
New +$6.74K ﹤0.01% 549

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Meridian Wealth Partners's BSX Position: Q2 2021 in Review

Meridian Wealth Partners sold out of Boston Scientific (BSX) in Q2 2021, closing a stake of 178 shares — an estimated $7K sold.

Meridian Wealth Partners first reported a position in BSX in Q1 2021 and held it in 1 quarter. The position peaked at $7K in Q1 2021. 867 funds tracked by Wall St. Rank hold BSX as of Q2 2021.

  • Meridian Wealth Partners reported no remaining Boston Scientific position as of Q2 2021 after selling out during the quarter.
  • Meridian Wealth Partners sold 178 Boston Scientific shares in Q2 2021, an estimated $7K.
  • Meridian Wealth Partners first reported a position in Boston Scientific in Q1 2021 and held it in 1 quarter.
  • Meridian Wealth Partners's Boston Scientific position peaked at $7K in Q1 2021.
  • 867 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2021.

Based on Meridian Wealth Partners's 13F filing for Q2 2021, filed 12 Aug 2021.